Glycosphingolipids and malignant growth
Dialovitskaia, E.V.
Voprosy Meditsinskoi Khimii 37(6): 21-23
1991
ISSN/ISBN: 0042-8809 PMID: 1812609 Document Number: 380808
Document emailed within 1 workday
Related Documents
Lenícková, L.; Smíd, F. 1997: Glycosphingolipids as tumor markers Casopis Lekaru Ceskych 136(21): 655-661Atzpodien, W.; Kremer, G.J. 1975: Plasma glycosphingolipids in hyperlipoproteinemias Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1432-1434
Hakomori, S.; Kannagi, R. 1983: Glycosphingolipids as tumor-associated and differentiation markers Journal of the National Cancer Institute 71(2): 231-251
Brudzyński, T.; Zieleński, J.; Kościelak, J. 1977: Mobilities of complex glycosphingolipids in SDS gel electrophoresis Acta Haematologica Polonica 8(4): 309-311
Ren, S.L.; Slominski, A.; Yu, R.K. 1989: Glycosphingolipids in Bomirski transplantable melanomas in hamsters Cancer Research 49(24 Part 1): 7051-7056
Fomina-Ageeva, E.V.; Diatlovitskaia, E.V.; Lemenovskaia, A.F.; Bergel'son, L.D. 1987: Glycosphingolipids from human T-lymphoma MOLT-4 cells Biokhimiia 52(11): 1777-1780
Sako, F. 1988: A novel blood group A- and O (H) -antigens--glycosphingolipids from porcine erythrocytes Hokkaido Journal of Medical Science 63(4): 534-544
Koyama, K.; Tamayama, C.; Tomono, Y.; Watanabe, K. 1983: Glycosphingolipids in clonal variants of rat fibrosarcoma cells with different transplantability Gan 74(4): 517-523
Taki, T. 1996: Cancer-associated alterations of glycoconjugates--special reference to glycosphingolipids Nihon Geka Gakkai Zasshi 97(2): 123-130
Dnistrian, A.M.; Skipski, V.P.; Barclay, M.; Stock, C.C. 1977: Alterations in glycosphingolipids of plasma membranes from Morris hepatoma 5123TC Cancer Research 37(7 Part 1): 2182-2187
Futerman, A.H. 1998: Distinct roles for sphingolipids and glycosphingolipids at different stages of neuronal development Acta Biochimica Polonica 45(2): 469-478
Slota, J.E.; Rittenhouse, H. 1990: Immunostaining technique for rapid detection of glycosphingolipids with enzymatically labeled probes Biotechniques 9(4): 394 396
Eto, Y.; Shinoda, S. 1982: Gangliosides and neutral glycosphingolipids in human brain tumors: specificity and their significance Advances in Experimental Medicine and Biology 152: 279-290
Furukawa, K. 2016: Molecular dynamics and regulatory mechanisms for signals of glycosphingolipids in membrane lipid rafts Seikagaku. Journal of Japanese Biochemical Society 88(3): 369-379
Zhang, J.; Zhang, J.; Yuan, Y. 2001: Investigation on the relationship between MDR and expression of N-glycosphingolipids in vincristine resistant KBv200 cell line Zhonghua Zhong Liu Za Zhi 23(2): 111-114
Burlakova, E.B.; Pal'mina, N.P. 1982: Regulatory function of membranes during malignant growth Vestnik Akademii Meditsinskikh Nauk SSSR 3: 74-86
Berezov, T.T. 1982: Amino acid metabolism and malignant growth Vestnik Akademii Meditsinskikh Nauk SSSR 9: 19-24
Ullman, M.D.; McCluer, R.H. 1987: High-pressure liquid chromatography analysis of neutral glycosphingolipids: perbenzoylated mono-, di-, tri-, and tetraglycosylceramides Methods in Enzymology 138: 117-125
Diatlovitskaia, E.V.; Sinitsyna, E.V.; Kliuchareva, T.E.; Matveeva, V.A.; Bergel'son, L.D. 1987: Inhibition of the cytotoxic activity of natural killer cells by glycosphingolipids. Effect of the structure of carbohydrate chains Voprosy Meditsinskoi Khimii 33(3): 95-98
Kwaan, H.C. 1988: Tumor growth and metastases in malignant disease. A review Journal of Medicine 19(3-4): 179-191